These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25952368)

  • 1. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
    Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
    Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.
    Shao Y; Ren H; Lv C; Ma X; Wu C; Wang Q
    Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study.
    Ren H; Wu C; Shao Y; Liu S; Zhou Y; Wang Q
    Front Med; 2020 Oct; 14(5):642-650. PubMed ID: 31950345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of hypoxia inducible Factor-1α in patients with diabetic nephropathy.
    Wang J; Ye S
    Niger J Clin Pract; 2019 Jun; 22(6):750-753. PubMed ID: 31187757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio.
    Ma X; Lu C; Lv C; Wu C; Wang Q
    J Diabetes Res; 2016; 2016():6789402. PubMed ID: 26881255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
    Shao Y; Lv C; Yuan Q; Wang Q
    J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy.
    Zhai Y; Cao X; Liu S; Shen Y
    Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
    Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
    J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract.
    Lai X; Tong D; Ai X; Wu J; Luo Y; Zuo F; Wei Z; Li Y; Huang W; Wang W; Jiang Q; Meng X; Zeng Y; Wang P
    Sci Rep; 2018 Nov; 8(1):16707. PubMed ID: 30420600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
    Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
    Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.
    Ibrahim S; Rashed L
    Saudi Med J; 2007 Apr; 28(4):519-23. PubMed ID: 17457470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-130b increases fibrosis of HMC cells by regulating the TGF-β1 pathway in diabetic nephropathy.
    Ma Y; Shi J; Wang F; Li S; Wang J; Zhu C; Li L; Lu H; Li C; Yan J; Zhang X; Jiang H
    J Cell Biochem; 2019 Mar; 120(3):4044-4056. PubMed ID: 30260005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential serum biomarkers for early detection of diabetic nephropathy.
    Motawi TK; Shehata NI; ElNokeety MM; El-Emady YF
    Diabetes Res Clin Pract; 2018 Feb; 136():150-158. PubMed ID: 29253627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy.
    Emara AM; El Bendary AS; Ahmed LM; Okda HI
    BMC Nephrol; 2024 Jul; 25(1):231. PubMed ID: 39030467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
    Khan S; Qayyum S; Khan MNA
    J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
    Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
    Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.
    Eroglu İ; Korkmaz H; Ozturk KH; Sirin FB; Sevik S; Afsar B
    Minerva Endocrinol (Torino); 2022 Sep; 47(3):314-324. PubMed ID: 33331738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.